Use of the Bioabsorbable Activa IM-Nail™ in Pediatric Diaphyseal Forearm Fractures
NCT ID: NCT04941612
Last Updated: 2021-06-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2021-05-25
2025-05-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pediatric diaphyseal forearm fractures are common and one of the most frequent reasons for orthopedic care. Fractures in need of surgery are often treated with metal Elastic Stable Intramedullary Nails (ESIN). Nail removal after 6-12 months is generally advocated. Surgical hardware removal has few complications; however, it is a substantial burden on the child, the family and healthcare economy. Bioabsorbable Intramedullary Nails (BIN) have been developed for the same indications as metal ESIN. The use of bioabsorbable implants would deem hardware removal unnecessary and relieve the child of further surgery and reduce healthcare costs.
Methods
The investigators aim to recruit all children in the catchment area of Herlev and Gentofte University Hospital (Copenhagen, Denmark) with acute unstable diaphyseal forearm fractures. Participants will be operated with BIN and followed consecutively for 2 years with interim analysis of data after 6 months. The investigators will report radiological healing using the Radiographic Union Score (RUS) 3 months after surgery together with any adverse events during follow-up.
Discussion
This study will provide important preliminary data and asses the feasibility of using the bioabsorbable Activa IM-Nail™ in pediatric diaphyseal forearm fractures. This study is a pilot study for initiating an RCT comparing BIN to metal ESIN hypothesizing that BIN is not an inferior treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioresorbable Intramedullary Nailing of Forearm Fractures
NCT04846543
Comparative Trial of Operative Treatment of Distal Pediatric Forearm Fractures With Biodegradable Nails and K-wires
NCT04848818
Casting Versus Flexible Intramedullary Nailing in Displaced Pediatric Forearm Shaft Fractures
NCT04664517
Clinical Evaluation of Cast21 Short Arm Product During Treatment of Distal Radial or Distal Ulnar Fractures
NCT06304649
Treatment of Unstable Both-Bone Midshaft Forearm Fractures in Children
NCT00314587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Activa IM-Nail
Activa IM-Nail
Activa IM-Nail
PLGA bioabsorbable intramedullary nail
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Activa IM-Nail
PLGA bioabsorbable intramedullary nail
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fractures need to be complete (not unicortical or green stick)
* Displaced more than 50% of bone width or angulated more than 10° in any plane or irreducible or unstable after reduction
Exclusion Criteria
* with fractures that are well managed conservatively (undisplaced or minimally displaced)
* with previous ipsilateral forearm fracture
* with fractures unsuited for intramedullary nailing (e.g. multifragmentary, metaphyseal or epiphyseal)
* with fractures with ipsilateral wrist or elbow involvement (e.g. Monteggia or Galeazzi variants)
* unable to participate in follow-up
* with existing bone pathology (e.g. tumor, osteogenesis imperfecta, degenerative disease)
* in whom internal fixation is otherwise contraindicated (e.g. active or potential infection)
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Fractures Interest Group, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Jon Andersen
Consultant Orthopedic Surgeon
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morten J Andersen, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herlev and Gentofte University Hospital
Herlev, Capital Region, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-21004012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.